Allarity Therapeutics, Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Allarity Therapeutics, Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
/ 
Frequently asked questions
To buy Allarity Therapeutics, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Allarity Therapeutics, Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Allarity Therapeutics, Inc. is ALLR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Allarity Therapeutics, Inc. has its primary listing on NASDAQ. You can trade Allarity Therapeutics, Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Allarity Therapeutics, Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Allarity Therapeutics, Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Allarity Therapeutics, Inc..